Key facts
- This page summarizes Todd C. Davis's Form 3 filing for PALVELLA THERAPEUTICS, INC. (PVLA).
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 16 Dec 2024, 19:41.
Todd C. Davis - 13 Dec 2024 Form 3 Insider Report for PALVELLA THERAPEUTICS, INC. (PVLA)
- Reporting relationship
- Director
- Issuer ticker
- PVLA
- Reported as of
- 13 Dec 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 16 Dec 2024, 19:41:24 UTC
- Prior SEC filing
- 15 Nov 2024
- Next SEC filing
- 19 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kathleen A. McGowan, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Todd C. Davis filed Form 3 for PALVELLA THERAPEUTICS, INC. (PVLA) on 16 Dec 2024.
Change
- Previous filing in this sequence was filed on 15 Nov 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PVLA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 112,547
- Date
- 13 Dec 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PVLA
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 13 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,642
- Exercise price
- $7.14
- Footnotes
- F1
PVLA
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 13 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 11,462
- Exercise price
- $7.53
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The stock option is fully vested.
Footnote F2
The stock option vests in equal monthly installments over a forty-eight month period. The option was granted on May 28, 2024.